Specifications - Exubera - Inhaled Insulin for Type 1 and Type 2 Diabetes

Key Data
Drug (brand/generic)	Exubera
Company/licensee	Aventis and Pfizer
Therapy class	Rapid-acting insulin
Product description	Inhaled insulin preparation
Current indication	Insulin-treated diabetes
Market sector	Diabetes
Development status	Product withdrawn in October 2007